Our website explains depression treatments, including TMS, Spravato and ketamine. People use it when making health decisions, so we hold it to clear standards. This page sets out who writes our content, who reviews it, which sources we rely on and how we keep it current.
Or call (646) 817-2835 to speak with our team
Medically reviewed by Yuli Fradkin, MD, board-certified psychiatrist · Last reviewed October 2026
Rated 5.0
On Google reviews
FDA-Cleared
Safe & evidence-based
In-Network
Aetna, BCBS, Cigna, United
Board-Certified
Psychiatrists, 15+ years each
WHO WRITES AND REVIEWS
Our pages and articles are written by the Village TMS content team. Writers work from the sources listed on this page and from the clinic’s own information about how we deliver care, such as session length, monitoring and insurance.
Every page with medical information is then reviewed by Yuli Fradkin, MD, a board-certified psychiatrist with more than 25 years of experience. He checks that the content is accurate, that it matches current guidance and that it describes risks and limits honestly.
A page with medical information goes live only after that review. Reviewed pages show a line near the top with the reviewer’s name and the month of the most recent review, so you can see how current the information is. You can meet the rest of our care team on our team page.
Our content explains options in general terms. It does not replace advice from a clinician who knows your history. If you are in crisis, call or text 988, or call 911.
OUR SOURCES
For what a drug is approved for and what a device is cleared for, we go to the U.S. Food and Drug Administration and its public records.
For background on depression, OCD, anxiety and other conditions, we use the National Institute of Mental Health, part of the National Institutes of Health.
For treatment results and side effects, we cite peer-reviewed studies indexed in PubMed, favoring randomized trials, meta-analyses and large reviews.
For dosing, monitoring and safety warnings, we use the official prescribing information published on the National Library of Medicine’s DailyMed.
OUR PROCESS
STEP 1
A writer drafts the page from primary sources and records the source behind each medical claim.
STEP 2
Dr. Fradkin reviews the draft for accuracy, safety information and regulatory wording, and asks for changes where needed.
STEP 3
The page goes live with a medically reviewed line that names the reviewer and the review date.
STEP 4
Each page is reviewed again at least once a year, and sooner when FDA labeling, clinical guidance or our own services change.
CORRECTIONS
Use our contact page or call (646) 817-2835. Include the page address and the statement you think is wrong.
The content team checks the statement against our sources and sends any medical question to Dr. Fradkin.
If the page is wrong, we fix it promptly and update the review date.
If you left your contact details, we let you know what we changed.
HOW WE DESCRIBE TREATMENTS
Words like cleared, approved and off-label have specific meanings, and getting them wrong can mislead you. We follow the same rules on every page.
When we describe a use that is not FDA-approved or FDA-cleared, we label it off-label or investigational and describe the evidence as it stands, including when it is early or mixed. We report response and remission rates only from published studies, worded as results seen in clinical studies, and we never promise an outcome.
If you find a page that breaks these rules, please tell us.
How we write, review and update our health information.
No. Our content explains conditions and treatments in general terms. It is not a substitute for a medical evaluation or for advice from a clinician who knows your history. Do not start, stop or change a medication without talking to your prescriber.
If you are in crisis or thinking about suicide, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911.
The Village TMS content team writes our pages and articles. Every page with medical information is reviewed by Yuli Fradkin, MD, before it is published.
Dr. Fradkin is a board-certified psychiatrist with more than 25 years of experience, affiliated with Mount Sinai. Read his full bio.
Each page is reviewed at least once a year. We review it sooner when FDA labeling, clinical guidance or our own services change. The review date appears near the top of the page.
The FDA reviews TMS devices through the 510(k) clearance pathway, so the correct word is cleared. Drugs such as Spravato go through the drug approval process, so the correct word for them is approved.
Off-label means a drug or device is used for a condition, or in a way, that the FDA has not approved or cleared it for. Doctors may use a treatment off-label when the evidence supports it. IV and IM ketamine for depression is one example, and we always label it as off-label.
Tell us through our contact page or call (646) 817-2835. Please include the page address and the statement you think is wrong.
EXPLORE OUR SERVICES
VISIT US
Our office is at 80 Fifth Avenue, at 14th Street. We see patients from across Manhattan, Brooklyn, Queens and New Jersey.
Greenwich Village ·
Chelsea · West Village ·
East Village · SoHo ·
Tribeca · Flatiron ·
Midtown
Williamsburg · Brooklyn
Heights · Park Slope ·
Long Island City · Astoria
· Forest Hills
Hoboken · Jersey City ·
Weehawken · Edgewater
· Fort Lee
